
Genetron Holdings Limited GTH
Annual report 2022
added 12-21-2024
Genetron Holdings Limited EBITDA per Share 2011-2025 | GTH
Annual EBITDA per Share Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -1.12 | -3.97 | -4.53 | -3.37 | -1.97 | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.12 | -4.53 | -2.99 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-0.16 | $ 19.16 | -1.11 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 20.5 | -4.92 % | $ 221 M | ||
|
Co-Diagnostics
CODX
|
-1.41 | $ 0.23 | -2.26 % | $ 6.75 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 39.2 | -0.49 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
7.64 | $ 230.58 | 0.1 % | $ 169 B | ||
|
DarioHealth Corp.
DRIO
|
-1.96 | $ 10.56 | 5.18 % | $ 300 M | ||
|
BioNano Genomics
BNGO
|
-70.8 | $ 1.5 | -1.07 % | $ 1.91 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
-4.08 | $ 101.62 | 0.04 % | $ 18.8 B | ||
|
DexCom
DXCM
|
2.03 | $ 67.79 | 0.33 % | $ 26.2 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 26.61 | -0.41 % | $ 805 M | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-3.51 | $ 19.02 | -2.36 % | $ 1.02 B | ||
|
Celcuity
CELC
|
-2.87 | $ 101.2 | -1.03 % | $ 3.99 B | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-434 | $ 3.2 | - | $ 102 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
18.3 | $ 226.58 | -0.15 % | $ 41.1 B | ||
|
Guardant Health
GH
|
-3.27 | $ 101.62 | -1.32 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
-0.69 | $ 6.35 | -2.08 % | $ 575 M | ||
|
ENDRA Life Sciences
NDRA
|
-20.1 | $ 4.81 | -5.39 % | $ 2.58 M | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 7.2 | 0.91 % | $ 1.56 B | ||
|
National Research Corporation
NRC
|
1.64 | $ 18.82 | 0.83 % | $ 462 M | ||
|
Illumina
ILMN
|
-3.01 | $ 133.99 | -0.71 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
11.5 | $ 203.2 | -0.17 % | $ 10.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
16.6 | $ 175.29 | -0.38 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
-0.22 | $ 6.8 | -0.29 % | $ 882 M | ||
|
Koninklijke Philips N.V.
PHG
|
0.61 | $ 27.25 | 0.53 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
20.6 | $ 253.12 | -0.33 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 183.24 | 0.22 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
15.3 | $ 684.16 | -0.63 % | $ 56.4 B | ||
|
Personalis
PSNL
|
-0.97 | $ 8.02 | -1.47 % | $ 475 M | ||
|
Lantheus Holdings
LNTH
|
7.54 | $ 66.86 | 0.22 % | $ 4.63 B | ||
|
Quidel Corporation
QDEL
|
3.59 | $ 29.14 | -0.55 % | $ 1.23 B | ||
|
Mettler-Toledo International
MTD
|
2.37 | $ 1 415.25 | -0.36 % | $ 30 B | ||
|
Agilent Technologies
A
|
5.49 | $ 138.08 | -0.22 % | $ 42 B | ||
|
RadNet
RDNT
|
3.32 | $ 73.09 | -0.08 % | $ 5.34 B |